mRNA cancer immunotherapy News

BioNTech Reports Stellar Q4 Revenue of €1.2 Billion Despite Challenges

BioNTech SE announced a 24.4% year-over-year decrease in Q4 revenue to €1.2 billion, surpassing analysts' expectations. Despite a net profit drop to €259.5 million from €457.9 mill...

BioNTech Reports Q4 Revenue of €1.2 Billion, Surpassing Market Expectations

BioNTech SE announced a Q4 revenue of €1.2 billion for fiscal 2024, a 24.4% year-over-year decrease but surpassing analysts' expectations. The company reported a net profit of €259...

BioNTech Reports a Staggering €1.2 Billion Revenue in Q4 2024 Amidst Challenges

BioNTech SE announced a Q4 2024 revenue of €1.2 billion, exceeding expectations despite a 24.4% year-over-year decrease. The company reported a net profit of €259.5 million, with d...